Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic

Peter M.A. Calverley
European Respiratory Journal 2017 50: 1701376; DOI: 10.1183/13993003.01376-2017
Peter M.A. Calverley
Clinical Science, University Hospital Aintree, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pmacal@liverpool.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Chronic breathlessness is an under-recognised problem irrespective of the terminology used to describe it http://ow.ly/kKQs30es6A8

From the author:

Morélot-Panzini and colleagues response to the paper by Johnson et al. [1] is an important contribution to the debate about the chronic breathlessness syndrome, which I called for in my editorial [2] and to which others have already contributed [3, 4]. English is a greedy language using words that mean the same in their original tongue to denote slight differences in meaning in English. In this case, dyspnoea is the technical term for breathlessness. In 40 years of clinical practice I never met a patient who complained of dyspnoea but saw many who were greatly affected by what they called breathlessness. This distinction between the symptom and its impact are at the heart of the discussions around the chronic breathlessness syndrome. I strongly support the need to provide more holistic care that looks at the consequences of breathlessness as well as their causes. However, important secondary effects on mood, behaviour and lifestyle occur in many chronic conditions not fully controlled by medical-management strategies. Should we refer to chronic arthritis syndrome or chronic cluster headache syndrome or any of the numerous other examples which readily suggest themselves? Whether or not we use the word syndrome these patients need better care than they currently receive.

Morélot-Panzini and colleagues make a cogent case for substituting the word “persistent” for “chronic” as it fits better with the problems they have identified in acute care. However, we should be cautious about making one term suit the needs of all circumstances. The clinical and societal impact of breathlessness is likely to be quite different for the patient in the intensive care unit needing ventilatory support after an acute illness and the patient with idiopathic hyperventilation who is an ambulatory outpatient. Making “one size fit all” will be a difficult task.

The major challenge ahead is not just to select the correct words (semantic arguments are of great interest to specialists but seldom advance the cause of patients) but instead to decide on the needs of patients with breathlessness and how best to meet them. If we focus on doing this then I suspect we will find the most appropriate words to describe those we are trying to help.

Footnotes

  • Conflict of interest: None declared.

  • Received July 9, 2017.
  • Accepted July 10, 2017.
  • Copyright ©ERS 2017

References

  1. ↵
    1. Johnson MJ,
    2. Yorke J,
    3. Hansen-Flaschen J
    , et al. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J 2017; 49: 1602277.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Calverley PMA
    . Chronic breathlessness: symptom or syndrome? Eur Respir J 2017; 49: 1700366.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Başoğlu M
    . Effective management of breathlessness: a review of potential human rights issues. Eur Respir J 2017; 49: 1602099.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Mularski RA
    . Advancing a common understanding and approach to dyspnea management. Consensus proposal for the chronic breathlessness syndrome. Ann Am Thorac Soc 2017; 14: 1108–1110.
    OpenUrl
View Abstract
Previous
Back to top
View this article with LENS
Vol 50 Issue 3 Table of Contents
European Respiratory Journal: 50 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic
Peter M.A. Calverley
European Respiratory Journal Sep 2017, 50 (3) 1701376; DOI: 10.1183/13993003.01376-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic
Peter M.A. Calverley
European Respiratory Journal Sep 2017, 50 (3) 1701376; DOI: 10.1183/13993003.01376-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • CTEPH and totally implantable central venous access systems
  • Ivacaftor modifies cystic fibrosis neutrophil phenotype
  • Serum mitochondrial DNA predicts exacerbation and progression of IPF
Show more Agora

Correspondence

  • Non-animal models for COVID-19 lung research
  • User-life of ICS/LABA inhaler devices should be considered
  • Peripheral blood eosinophil counts in European and East Asian populations
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society